Latest On Rubius Therapeutics, Inc (RUBY):
About Rubius Therapeutics, Inc (RUBY):
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of cancer; and RTX-aAPC to treat solid and hematological cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
General
- Name Rubius Therapeutics, Inc
- Symbol RUBY
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 204
- Fiscal Year EndDecember
- IPO Date2018-07-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.rubiustx.com
Valuation
- Price/Book (Most Recent Quarter) 13.87
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.10
- Next Year EPS Estimate -$2.11
- Next Quarter EPS Estimate -$0.50
- Return on Assets -31%
- Return on Equity -81%
- Earnings Per Share -$1.70
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 1.97 billion
- EBITDA -130160000
- Analyst Target Price $27.4
- Book Value Per Share $1.75
Share Statistics
- Shares Outstanding 81.18 million
- Shares Float 32.06 million
- % Held by Insiders 799%
- % Held by Institutions 94.8%
- Shares Short 7.5 million
- Shares Short Prior Month 7.41 million
- Short Ratio 7.92
- Short % of Float 28%
- Short % of Shares Outstanding 9%
Technicals
- Beta 2.2
- 52 Week High $29.63
- 52 Week Low $3.83
- 50 Day Moving Average 13.94
- 200 Day Moving Average 8.21
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Rubius Therapeutics, Inc (RUBY) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Rubius Therapeutics, Inc (RUBY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-23 | $N/A | -$0.50 | -$0.53 | 4.94% |
2020-09-30 | 2020-11-09 | $N/A | -$0.51 | -$0.50 | -2.7% |
2020-06-30 | 2020-08-10 | $N/A | -$0.47 | -$0.50 | 6.47% |
2020-03-31 | 2020-05-11 | $N/A | -$0.60 | -$0.56 | -7.89% |
2019-12-31 | 2020-03-12 | $N/A | -$0.56 | -$0.64 | 12.57% |
2019-09-30 | 2019-11-14 | $N/A | -$0.59 | -$0.56 | -5.56% |
2019-06-30 | 2019-08-13 | $N/A | -$0.50 | -$0.48 | -3.28% |
2019-03-31 | 2019-05-15 | $N/A | -$0.42 | -$0.41 | -1.35% |
2018-12-31 | 2019-03-28 | $N/A | -$0.35 | -$0.42 | 16.51% |
2018-09-30 | 2018-11-13 | $N/A | -$0.42 | -$0.36 | -16.54% |
2018-06-30 | 2018-08-31 | $N/A | -$0.43 | -$0.30 | -41.68% |
Rubius Therapeutics, Inc (RUBY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Rubius Therapeutics, Inc (RUBY) Chart:
Rubius Therapeutics, Inc (RUBY) News:
Below you will find a list of latest news for Rubius Therapeutics, Inc (RUBY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Rubius Therapeutics, Inc (RUBY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest RUBY Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 200 | $0.8926 |
Jun 13, 2022 7:59 PM EST | 7 | $0.8926 |
Jun 13, 2022 7:59 PM EST | 68 | $0.8926 |
Jun 13, 2022 7:59 PM EST | 21 | $0.8926 |
Jun 13, 2022 7:59 PM EST | 95 | $0.8926 |
Rubius Therapeutics, Inc (RUBY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920078435/0001104659-20-078435-index.htm |
2019-08-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1709401/000000000019012197/0000000000-19-012197-index.htm |
2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000031506619001262/0000315066-19-001262-index.htm |
2019-11-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000031506619001755/0000315066-19-001755-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000031506620001145/0000315066-20-001145-index.htm |
2018-07-18 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1709401/000104746918005073/0001047469-18-005073-index.htm |
2019-04-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1709401/000104746919002211/0001047469-19-002211-index.htm |
2019-08-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1709401/000104746919004493/0001047469-19-004493-index.htm |
2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1709401/000104746920002200/0001047469-20-002200-index.htm |
2019-01-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000108887519000014/0001088875-19-000014-index.htm |
2020-01-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000108887520000018/0001088875-20-000018-index.htm |
2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045597/0001104659-18-045597-index.htm |
2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045598/0001104659-18-045598-index.htm |
2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045599/0001104659-18-045599-index.htm |
2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045600/0001104659-18-045600-index.htm |
2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045601/0001104659-18-045601-index.htm |
2018-07-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045764/0001104659-18-045764-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045771/0001104659-18-045771-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045772/0001104659-18-045772-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045773/0001104659-18-045773-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045774/0001104659-18-045774-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045775/0001104659-18-045775-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045776/0001104659-18-045776-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045777/0001104659-18-045777-index.htm |
2018-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918045778/0001104659-18-045778-index.htm |
2018-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046523/0001104659-18-046523-index.htm |
2018-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046526/0001104659-18-046526-index.htm |
2018-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046528/0001104659-18-046528-index.htm |
2018-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046530/0001104659-18-046530-index.htm |
2018-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046532/0001104659-18-046532-index.htm |
2018-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046534/0001104659-18-046534-index.htm |
2018-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046838/0001104659-18-046838-index.htm |
2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918048790/0001104659-18-048790-index.htm |
2018-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918054635/0001104659-18-054635-index.htm |
2018-08-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000110465918054637/0001104659-18-054637-index.htm |
2018-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465918065519/0001104659-18-065519-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918067460/0001104659-18-067460-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918067738/0001104659-18-067738-index.htm |
2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000110465918067739/0001104659-18-067739-index.htm |
2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465918074479/0001104659-18-074479-index.htm |
2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/0001104659-19-002512-index.htm |
2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919002584/0001104659-19-002584-index.htm |
2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919003193/0001104659-19-003193-index.htm |
2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919005603/0001104659-19-005603-index.htm |
2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919005604/0001104659-19-005604-index.htm |
2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919005605/0001104659-19-005605-index.htm |
2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919005606/0001104659-19-005606-index.htm |
2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000110465919008821/0001104659-19-008821-index.htm |
2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919008822/0001104659-19-008822-index.htm |
2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919013736/0001104659-19-013736-index.htm |
2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919016067/0001104659-19-016067-index.htm |
2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919017131/0001104659-19-017131-index.htm |
2019-03-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919017892/0001104659-19-017892-index.htm |
2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919018062/0001104659-19-018062-index.htm |
2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919019036/0001104659-19-019036-index.htm |
2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919020219/0001104659-19-020219-index.htm |
2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919020731/0001104659-19-020731-index.htm |
2019-04-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1709401/000110465919021135/0001104659-19-021135-index.htm |
2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/0001104659-19-022064-index.htm |
2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919031516/0001104659-19-031516-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032118/0001104659-19-032118-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032119/0001104659-19-032119-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032120/0001104659-19-032120-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032121/0001104659-19-032121-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032122/0001104659-19-032122-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032123/0001104659-19-032123-index.htm |
2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919032124/0001104659-19-032124-index.htm |
2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919037241/0001104659-19-037241-index.htm |
2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/0001104659-19-040757-index.htm |
2019-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919042118/0001104659-19-042118-index.htm |
2019-08-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1709401/000110465919045115/0001104659-19-045115-index.htm |
2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919045429/0001104659-19-045429-index.htm |
2019-08-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1709401/000110465919046536/0001104659-19-046536-index.htm |
2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919050627/0001104659-19-050627-index.htm |
2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/0001104659-19-054477-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919063717/0001104659-19-063717-index.htm |
2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919065987/0001104659-19-065987-index.htm |
2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919069692/0001104659-19-069692-index.htm |
2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919073590/0001104659-19-073590-index.htm |
2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919073955/0001104659-19-073955-index.htm |
2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465919075314/0001104659-19-075314-index.htm |
2019-12-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465919076260/0001104659-19-076260-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920000769/0001104659-20-000769-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920003243/0001104659-20-003243-index.htm |
2020-01-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920003444/0001104659-20-003444-index.htm |
2020-01-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920007739/0001104659-20-007739-index.htm |
2020-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920009345/0001104659-20-009345-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920010062/0001104659-20-010062-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920010063/0001104659-20-010063-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920010064/0001104659-20-010064-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920010065/0001104659-20-010065-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920032144/0001104659-20-032144-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920034857/0001104659-20-034857-index.htm |
2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920036113/0001104659-20-036113-index.htm |
2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1709401/000110465920044866/0001104659-20-044866-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000110465920047001/0001104659-20-047001-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920059157/0001104659-20-059157-index.htm |
2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920065450/0001104659-20-065450-index.htm |
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920078435/0001104659-20-078435-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920092420/0001104659-20-092420-index.htm |
2020-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000110465920109133/0001104659-20-109133-index.htm |
2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020005089/0001179110-20-005089-index.htm |
2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006356/0001179110-20-006356-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006601/0001179110-20-006601-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006602/0001179110-20-006602-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006603/0001179110-20-006603-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006604/0001179110-20-006604-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006605/0001179110-20-006605-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006606/0001179110-20-006606-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006611/0001179110-20-006611-index.htm |
2020-10-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1709401/000117911020010359/0001179110-20-010359-index.htm |
2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000119312519036248/0001193125-19-036248-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1709401/000142284920000105/0001422849-20-000105-index.htm |
2019-03-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1709401/000155837019002516/0001558370-19-002516-index.htm |
2019-05-15 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1709401/000155837019005041/0001558370-19-005041-index.htm |
2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1709401/000155837019005043/0001558370-19-005043-index.htm |
2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000155837019005047/0001558370-19-005047-index.htm |
2019-05-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1709401/000155837019005049/0001558370-19-005049-index.htm |
2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000155837019008018/0001558370-19-008018-index.htm |
2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000155837019010992/0001558370-19-010992-index.htm |
2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1709401/000155837020002475/0001558370-20-002475-index.htm |
2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1709401/000155837020002477/0001558370-20-002477-index.htm |
2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000155837020006124/0001558370-20-006124-index.htm |
2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1709401/000155837020010055/0001558370-20-010055-index.htm |
2018-07-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1709401/999999999518001813/9999999995-18-001813-index.htm |
2019-08-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1709401/999999999519001940/9999999995-19-001940-index.htm |
Rubius Therapeutics, Inc (RUBY) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rubius Therapeutics, Inc (RUBY). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 799%Institutional Ownership: 9480%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-01-14 | ROBERT LANGER | Director | Sell | 7,500.00 | 14.59 | 109,443.75 | 0.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/0001104659-19-002512-index.htm |
2019-04-15 | ROBERT LANGER | Director | Sell | 7,500.00 | 17.57 | 131,799.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/0001104659-19-022064-index.htm |
2019-07-15 | ROBERT LANGER | Director | Sell | 7,500.00 | 14.94 | 112,048.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/0001104659-19-040757-index.htm |
2019-10-14 | ROBERT LANGER | Director | Sell | 7,500.00 | 8.52 | 63,874.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/0001104659-19-054477-index.htm |
2018-07-20 | Roger Pomerantz | Director | Buy | 100.00 | 23.00 | 2,300.00 | 100.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046530/0001104659-18-046530-index.htm |
2018-07-20 | Francis M Cuss | Director | Buy | 10,000.00 | 23.00 | 230,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046528/0001104659-18-046528-index.htm |
2019-04-08 | TORBEN STRAIGHT NISSEN | President | Sell | 2,100.00 | 20.00 | 42,000.00 | 1,845,304.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919020731/0001104659-19-020731-index.htm |
2019-04-05 | TORBEN STRAIGHT NISSEN | President | Sell | 12,096.00 | 20.00 | 241,920.00 | 1,847,404.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919020219/0001104659-19-020219-index.htm |
2019-04-03 | TORBEN STRAIGHT NISSEN | President | Sell | 500.00 | 20.00 | 10,000.00 | 1,859,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919020219/0001104659-19-020219-index.htm |
2020-04-22 | Christina M. Coughlin | Chief Medical Officer | Buy | 19,000.00 | 5.52 | 104,813.50 | 19,000.00 | https://www.sec.gov/Archives/edgar/data/1709401/000117911020005089/0001179110-20-005089-index.htm |
2019-07-24 | TORBEN STRAIGHT NISSEN | President | Buy | 175,000.00 | 0.18 | 31,500.00 | 2,020,304.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919042118/0001104659-19-042118-index.htm |
2019-07-24 | TORBEN STRAIGHT NISSEN | President | Buy | 32,146.00 | 0.19 | 6,107.74 | 2,052,450.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919042118/0001104659-19-042118-index.htm |
2020-04-14 | PABLO J CAGNONI | CEO and President | Buy | 21,000.00 | 4.70 | 98,693.70 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465920047001/0001104659-20-047001-index.htm |
2018-07-20 | Catherine A. Sohn | Director | Buy | 2,500.00 | 23.00 | 57,500.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046532/0001104659-18-046532-index.htm |
2018-07-20 | Jonathan Symonds | Director | Buy | 25,000.00 | 23.00 | 575,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465918046526/0001104659-18-046526-index.htm |
2019-01-22 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 34,843.00 | 2.87 | 99,999.41 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919003193/0001104659-19-003193-index.htm |
2019-03-15 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 48,000.00 | 15.84 | 760,113.60 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919016067/0001104659-19-016067-index.htm |
2019-06-17 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 18,500.00 | 14.10 | 260,868.50 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-06-18 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 10,858.00 | 14.27 | 154,957.78 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-06-19 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 18,399.00 | 13.80 | 253,867.56 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-06-20 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 243.00 | 13.93 | 3,385.96 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919037241/0001104659-19-037241-index.htm |
2019-09-16 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 36,123.00 | 10.13 | 365,897.09 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919050627/0001104659-19-050627-index.htm |
2019-09-17 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 11,877.00 | 10.05 | 119,309.22 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919050627/0001104659-19-050627-index.htm |
2019-12-16 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Sell | 48,000.00 | 13.48 | 646,900.80 | 34,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919073955/0001104659-19-073955-index.htm |
2019-06-20 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 243.00 | 2.87 | 697.41 | 35,086.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919037241/0001104659-19-037241-index.htm |
2019-06-18 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 10,858.00 | 2.87 | 31,162.46 | 45,701.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-09-17 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 11,877.00 | 2.87 | 34,086.99 | 46,720.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919050627/0001104659-19-050627-index.htm |
2020-03-13 | David R Epstein | Director | Buy | 5,000.00 | 3.82 | 19,100.00 | 4,805,453.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465920034857/0001104659-20-034857-index.htm |
2020-03-13 | David R Epstein | Director | Buy | 5,000.00 | 4.00 | 20,000.00 | 4,810,453.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465920034857/0001104659-20-034857-index.htm |
2020-03-17 | David R Epstein | Director | Buy | 5,000.00 | 3.76 | 18,800.00 | 4,815,453.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465920036113/0001104659-20-036113-index.htm |
2020-05-15 | ANDREW M. OH | Chief Financial Officer | Buy | 5,000.00 | 4.74 | 23,700.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1709401/000117911020006356/0001179110-20-006356-index.htm |
2019-06-19 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 18,399.00 | 2.87 | 52,805.13 | 53,242.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-06-17 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 18,500.00 | 2.87 | 53,095.00 | 53,343.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919036506/0001104659-19-036506-index.htm |
2019-09-16 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 36,123.00 | 2.87 | 103,673.01 | 70,966.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919050627/0001104659-19-050627-index.htm |
2019-01-14 | ROBERT LANGER | Director | Buy | 7,500.00 | 0.15 | 1,125.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/0001104659-19-002512-index.htm |
2019-04-15 | ROBERT LANGER | Director | Buy | 7,500.00 | 0.15 | 1,125.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/0001104659-19-022064-index.htm |
2019-07-15 | ROBERT LANGER | Director | Buy | 7,500.00 | 0.15 | 1,125.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/0001104659-19-040757-index.htm |
2019-10-14 | ROBERT LANGER | Director | Buy | 7,500.00 | 0.15 | 1,125.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/0001104659-19-054477-index.htm |
2019-03-15 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 48,000.00 | 2.87 | 137,760.00 | 82,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919016067/0001104659-19-016067-index.htm |
2019-12-16 | CHRISTOPHER L. CARPENTER | Chief Medical Officer | Buy | 48,000.00 | 2.87 | 137,760.00 | 82,843.00 | https://www.sec.gov/Archives/edgar/data/1709401/000110465919073955/0001104659-19-073955-index.htm |